Formela Jean Francois's Form 4 filing
Korro Bio, Inc. (KRRO) · filed Jul 7, 2026
- Accession no.
- 0001030575-26-000006
- Filed
- Jul 7, 2026, 6:04 PM ET
- Trade date
- Jul 2-6, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.54M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Formela Jean FrancoisCIK 0001030575 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | SSaleDisposed | −85,955 | $14.03 | −$1,205,948.65 | 707,373 | Indirect | |
| Jul 2, 2026 | Common Stock | SSaleDisposed | −14,745 | $14.03 | −$206,872.35 | 154,811 | Indirect | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −817 | $13.96 | −$11,405.32 | 706,556 | Indirect | |
| Jul 6, 2026 | Common Stock | SSaleDisposed | −8,506 | $13.96 | −$118,743.76 | 146,305 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.